29.07.2016 Views

Malignant Ascites Market with Current Trends Analysis,2016-2026

Future Market Insights has announced the addition of the “Malignant Ascites Market: Global Industry Analysis and Opportunity Assessment 2016-2026”report to their offering.

Future Market Insights has announced the addition of the “Malignant Ascites Market: Global Industry Analysis and Opportunity Assessment 2016-2026”report to their offering.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Global <strong>Malignant</strong><br />

<strong>Ascites</strong> <strong>Market</strong><br />

Share, Global <strong>Trends</strong>,<br />

<strong>Analysis</strong>, Research, Report,<br />

Opportunities,<br />

Segmentation and Forecast,<br />

<strong>2016</strong><br />

Future <strong>Market</strong> Insights<br />

www.futuremarketinsights.com<br />

sales@futuremarketinsights.com


Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting<br />

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.<br />

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.<br />

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and<br />

Retail.<br />

We have a global presence <strong>with</strong> delivery centers across India specializing in providing global research reports and country<br />

research reports. FMI is headquartered out of London, U.K., <strong>with</strong> a state-of-the-art delivery center located in Pune, India.<br />

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for<br />

our client.<br />

Research Capabilities<br />

• Customized Research<br />

• Syndicated Research<br />

• Investment Research<br />

• Social Media Research<br />

Sector Coverage<br />

• Automotive and Transportation<br />

• Electronics, Semiconductor, and ICT<br />

• Retail and Consumer Products<br />

• Industrial Automation and Equipment<br />

• Chemicals & Materials<br />

• Food and Beverages<br />

• Services and Utilities<br />

• Energy, Mining, Oil, and Gas<br />

Customized<br />

Research<br />

Syndicated<br />

Research<br />

Investment<br />

Research<br />

Social Media<br />

Research<br />

Subscription Information<br />

For detailed subscription information please contact<br />

Hari. T (Sr. Manager - Global Business Development)<br />

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />

Email: hari.t@futuremarketinsights.com


Report Description<br />

<strong>Ascites</strong> is the formation of excessive fluid in the space surrounding the organs in the<br />

abdomen, especially in the peritoneal cavity. It occurs because of the body is unable to<br />

remove fluids it produced. <strong>Ascites</strong> can occur in normal conditions as well as in cancer<br />

condition. When ascites occurs due to cancer, often called malignant ascites or malignant<br />

peritoneal effusion. <strong>Malignant</strong> cells causes irritation in the layers of the abdomen and it<br />

leads to production of excessive body fluids. Usually, lymph glands drain excessive body<br />

fluids from the body, but, in ascites condition, lymph glands become blocked and it leads<br />

to outbreaks of ascites symptoms include loss of sleep, skin problems, fatigue, low blood<br />

pressure, and problems <strong>with</strong> self-esteem. <strong>Malignant</strong> ascites caused by different health<br />

conditions such as, irritation of the thin membrane of abdomen, destruction in lymphatic<br />

system, and disturbances in the liver function due to the cancer cells.<br />

Symptoms of malignant ascites depends on various factors. Main symptoms in the<br />

malignant ascites includes swelling of the abdomen, feeling of bloating, abdominal<br />

discomfort or pain, fatigue, shortness of breath, weight gain, constipation and ankle or<br />

leg swelling.<br />

Request for sample report: http://www.futuremarketinsights.com/reports/sample/repgb-1658<br />

For diagnosis of malignant ascites, x-ray test, physical examination, ultrasound and CT<br />

scans are available. However, physical examinations is not effective in an obese patient<br />

cases.


Report Description<br />

For the treatment malignant ascites, diuretics, chemotherapy, paracentesis and surgeries<br />

are available. Diuretics are used for the removal of more fluids from the body and it is<br />

effective treatment in this disease condition. Paracentesis is a process of removal of body<br />

fluid by using a catheter and it is used when the diuretics are not effective and the<br />

patients are suffering from breathing problems. Food and Drug Administration (FDA),<br />

recently approved PleurX catheter, for the treatment of malignant ascites. Chemotherapy<br />

drugs are used in the treatment of malignant ascites and physician give drugs directly to<br />

the intra peritoneal cavity of the patient for more effective.<br />

<strong>Malignant</strong> <strong>Ascites</strong> market has been classified on the basis of treatment and distribution<br />

channel<br />

<strong>Malignant</strong> <strong>Ascites</strong> by Treatment Type<br />

Chemotherapy<br />

Diuretics<br />

Paracentesis<br />

Surgery<br />

<strong>Malignant</strong> <strong>Ascites</strong> by Distribution Channel<br />

Hospitals<br />

Diagnostic Centres


Report Description<br />

Clinics<br />

Retail Pharmacies<br />

Ambulatory Surgical Centre<br />

Lack of awareness about the disease is major restraint for malignant ascites market,<br />

especially in the obese patient the diagnosis of disease is slightly difficult by physical<br />

examination.<br />

Increase in the prevalence rate of various cancers, ovarian cancer, breast cancer, bowel<br />

cancer, stomach cancer, pancreatic cancer, mesothelioma in the peritoneum, lung cancer,<br />

liver cancer and womb cancer is expected to drive the malignant ascites market owing to<br />

the chances of ascites is high in patients who are suffering from these cancers.<br />

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1658<br />

Depending on geographic region, <strong>Malignant</strong> <strong>Ascites</strong> market is segmented into seven key<br />

regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.<br />

North America is estimated to contribute maximum revenue share in the global market<br />

of <strong>Malignant</strong> <strong>Ascites</strong> followed by Europe. Asia Pacific regions are expected to grow at a<br />

higher growth rate owing to high occurrence of cancer diseases. Middle East & Africa is<br />

expected to show a healthy growth rate in a forecast period.


Report Description<br />

Key players of malignant ascites market are BD, Actavis elizabeth llc, Sandoz inc, Mylan<br />

pharmaceuticals inc, Trion Pharma, GE healthcare, Siemens AG, and Fresenius Biotech.


Thank You!<br />

To know more about us, please visit our website:<br />

www.futuremarketinsights.com<br />

For sales queries or new topics email us on:<br />

sales@futuremarketinsights.com<br />

Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />

Valley Cottage, NY 10989, United States<br />

T: +1-347-918-3531 | D: +1-845-579-5705

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!